Waltz Health, a Chicago-based technology startup, is revolutionizing the prescription care industry with an innovative approach to reducing costs and enhancing consumer experiences. Founded in 2021, Waltz Health addresses challenges in the pharmaceutical supply chain by introducing AI-driven marketplaces and consumer-centric tools designed to empower both consumers and businesses.
The company's solutions cater to a broad spectrum of stakeholders, including payers, pharmacies, and individual consumers, offering a strategic edge through better pricing and informed decision-making. By leveraging cutting-edge technology, Waltz Health aims to deliver improved health outcomes and foster collaborative efforts across the industry.
In April 2022, Waltz Health secured a significant $35.00M Series A investment from notable investors such as GV, Byers Capital, Define Ventures, Echo Health Ventures, Twine Ventures, and The Blue Venture Fund, highlighting confidence in their transformative vision.